BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27032812)

  • 1. An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis (.).
    Shemer A; Gupta AK; Amichai B; Farhi R; Baran R; Daniel CR; Daigle D; Foley KA
    J Dermatolog Treat; 2016 Oct; 27(5):480-3. PubMed ID: 27032812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antifungal medication for toenail onychomycosis.
    Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
    Jaiswal A; Sharma RP; Garg AP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
    Baran R; Feuilhade M; Combernale P; Datry A; Goettmann S; Pietrini P; Viguie C; Badillet G; Larnier C; Czernielewski J
    Br J Dermatol; 2000 Jun; 142(6):1177-83. PubMed ID: 10848743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
    Yadav P; Singal A; Pandhi D; Das S
    Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis.
    Gupta AK; Foley KA; Mays RR; Shear NH; Piguet V
    Br J Dermatol; 2020 Feb; 182(2):287-299. PubMed ID: 31120134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
    Elewski BE; Ghannoum MA; Mayser P; Gupta AK; Korting HC; Shouey RJ; Baker DR; Rich PA; Ling M; Hugot S; Damaj B; Nyirady J; Thangavelu K; Notter M; Parneix-Spake A; Sigurgeirsson B
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):287-94. PubMed ID: 22181693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical comparison and complete cure rates of Terbinafine efficacy in affected onychomycotic toenails.
    Shemer A; Sakka N; Baran R; Scher R; Amichai B; Norman L; Farhi R; Magun R; Brazilai A; Daniel R
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):521-6. PubMed ID: 25079781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for cure following treatment of onychomycosis.
    Sigurgeirsson B
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):679-84. PubMed ID: 19929941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data.
    Epstein E
    Arch Dermatol; 1998 Dec; 134(12):1551-4. PubMed ID: 9875192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.
    Farkas B; Paul C; Dobozy A; Hunyadi J; Horváth A; Fekete G
    Br J Dermatol; 2002 Feb; 146(2):254-60. PubMed ID: 11903236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
    Bräutigam M; Nolting S; Schopf RE; Weidinger G
    BMJ; 1995 Oct; 311(7010):919-22. PubMed ID: 7580551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.